Buscar
Mostrando ítems 1-10 de 301
Aspectos clínicos y farmacoterapéuticos de la infección del tracto urinario : revisión estructuradaClinical and therapeutic aspects in the treatment of urinary tract infection : structured review
(Universidad CES, Facultad de MedicinaPromoción y Prevención FarmacéuticaMedellín, Colombia, 2021)
Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial
(Springer, 2019)
Objective: The aim of this study was to investigate long-term clinical outcomes of extended treatment with CT-P10, a rituximab biosimilar, compared with rituximab reference products sourced from the USA and the EU (US-RTX ...
Contribuição laboratorial para a diferenciação entre colonização e infecção por leveduras em pacientes hospitalizadosLaboratorial contribution for differentiation between colonisation and infection caused by yeast in hospitalized patients
(Universidade Estadual de MaringáBrasilDepartamento de Análises ClínicasPrograma de Pós-Graduação em Biociências Aplicadas à FarmáciaUEMMaringá, PRCentro de Ciências da Saúde, 2018)
Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort
(SAGE Publications, 2019)
AIM: The aim of this study was to identify factors predictive of serious infections over time in patients with systemic lupus erythematosus (SLE). METHODS: A multi-ethnic, multi-national Latin American SLE cohort was ...
Infecção do trato urinário adquirida em ambiente hospitalar em idosos
(2010)
Introduction: Hospital-acquired urinary tract infection (HAUTI) is an important cause of morbidity in the elderly population. Objective: Evaluate the occurrence of HAUTI and risk factors associated with it. Method: This ...
Classification of Avian Pathogenic Escherichia coli (APEC) and Human Uropathogenic Escherichia coli (UPEC) in Phylogenetic Groups and Association with Pathogenicity In Vivo
(Universidade Federal do Rio Grande do Sul, 2017)
Orbifloxacin: A Review of Properties, Its Antibacterial Activities, Pharmacokinetic/Pharmacodynamic Characteristics, Therapeutic Use, and Analytical Methods
(2013-05-01)
Orbifloxacin is a third generation of fluoroquinolone that exhibits increased antibacterial activity against the Enterobacteriaceae, gram-negative and gram-positive bacteria, anaerobes, and mycobacteria. This drug was ...
Orbifloxacin: A Review of Properties, Its Antibacterial Activities, Pharmacokinetic/Pharmacodynamic Characteristics, Therapeutic Use, and Analytical Methods
(2013-05-01)
Orbifloxacin is a third generation of fluoroquinolone that exhibits increased antibacterial activity against the Enterobacteriaceae, gram-negative and gram-positive bacteria, anaerobes, and mycobacteria. This drug was ...